000 01604 a2200421 4500
005 20250512003006.0
264 0 _c19900124
008 199001s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(89)90694-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLavan, B E
245 0 0 _aResolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
_h[electronic resource]
260 _bBiochemical pharmacology
_cNov 1989
300 _a4123-36 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a1-Methyl-3-isobutylxanthine
_xpharmacology
650 0 4 _a3',5'-Cyclic-AMP Phosphodiesterases
_xantagonists & inhibitors
650 0 4 _a3',5'-Cyclic-GMP Phosphodiesterases
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aCalcium
_xpharmacology
650 0 4 _aCalmodulin
_xpharmacology
650 0 4 _aChromatography, DEAE-Cellulose
650 0 4 _aChromatography, Ion Exchange
650 0 4 _aCyclic AMP
_xmetabolism
650 0 4 _aCyclic GMP
_xmetabolism
650 0 4 _aCytosol
_xenzymology
650 0 4 _aKinetics
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aTheophylline
_xanalogs & derivatives
700 1 _aLakey, T
700 1 _aHouslay, M D
773 0 _tBiochemical pharmacology
_gvol. 38
_gno. 22
_gp. 4123-36
856 4 0 _uhttps://doi.org/10.1016/0006-2952(89)90694-1
_zAvailable from publisher's website
999 _c2486798
_d2486798